Markers of sulfadoxine-pyrimethamine resistance in Eastern Democratic Republic of Congo; implications for malaria chemoprevention (scientific article published on 18 December 2019)

Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis

Q26795623

Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis

Q26849714

Mapping Plasmodium falciparum Mortality in Africa between 1990 and 2015

Q27198237

Travel and the emergence of high-level drug resistance in Plasmodium falciparum in southwest Uganda: results from a population-based study

Q33568493

Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia

Q33950981

Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania

Q34885646

Drug resistance maps to guide intermittent preventive treatment of malaria in African infants

Q35228689

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali

Q36143003

Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea

Q36144097

Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model.

Q36292865

Impact of Sulfadoxine-Pyrimethamine Resistance on Effectiveness of Intermittent Preventive Therapy for Malaria in Pregnancy at Clearing Infections and Preventing Low Birth Weight

Q36603993

Low prevalence of Plasmodium malariae and Plasmodium ovale mono-infections among children in the Democratic Republic of the Congo: a population-based, cross-sectional study

Q37080327

Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria

Q38136762

Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa

Q38636047

Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda

Q38876271

Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda

Q38882145

Beyond malaria--causes of fever in outpatient Tanzanian children

Q38958988

Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial

Q39029567

Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey.

Q40340398

Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity

Q42620908

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria

Q43864384

Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR.

Q44146886

Drug Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo using high-throughput Molecular Inversion Probes.

Q53689124

Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.

Q53701891

Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial

Q56362278

Molecular identification of Plasmodium species in symptomatic children of Democratic Republic of Congo

Q58711527

Mefloquine for preventing malaria in pregnant women

Q62488463

The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density

Q64104328

Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study

Q91253733

P433

issue

P921

main subject

malaria

Q12156

P304

page(s)

430

P577

publication date